Literature DB >> 7381003

Lactose-positive Vibrio in seawater: a cause of pneumonia and septicemia in a drowning victim.

M T Kelly, D M Avery.   

Abstract

Lactose-positive Vibrio is a recently recognized marine organism that has pathogenic potential for humans. An organism was isolated from the sputum and blood of a man who was resuscitated after drowning in the sea. The isolates from both sources had the characteristics of lactose-positive Vibrio, which include positive oxidase, citrate, indole, and o-nitrophenyl-beta-D-galactopyranoside reactions and negative Voges-Proskauer, urease, and sucrose reactions. Seawater samples from 21 sites around Galveston Island were cultured for lactose-positive Vibrio over a period of 4 weeks, and 36% of the samples yielded the organism. The environmental isolates were very similar to the clinical isolates in biochemical reactions and susceptibility to antimicrobial agents. The results indicate that lactose-positive Vibrio is a common organism in the marine environment and that it should be considered in the diagnosis of infections, including pneumonia, associated with exposure to the sea.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7381003      PMCID: PMC273379          DOI: 10.1128/jcm.11.3.278-280.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Halophilic, lactose-positive Vibrio in a case of fatal septicemia.

Authors:  A Mertens; J Nagler; W Hansen; E Gepts-Friedenreich
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

2.  Vibrio parahaemolyticus outbreaks in the United States.

Authors:  W H Barker
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

3.  Leg gangrene and endotoxin shock due to vibrio parahaemolyticus--an infection acquired in New England coastal waters.

Authors:  F P Roland
Journal:  N Engl J Med       Date:  1970-06-04       Impact factor: 91.245

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

5.  Halophilic Vibrio species isolated from blood cultures.

Authors:  D G Hollis; R E Weaver; C N Baker; C Thornsberry
Journal:  J Clin Microbiol       Date:  1976-04       Impact factor: 5.948

6.  Vibrio alginolyticus wound infection: case report and review.

Authors:  R P Spark; M L Fried; C Perry; C Watkins
Journal:  Ann Clin Lab Sci       Date:  1979 Mar-Apr       Impact factor: 1.256

7.  Disease caused by a marine Vibrio. Clinical characteristics and epidemiology.

Authors:  P A Blake; M H Merson; R E Weaver; D G Hollis; P C Heublein
Journal:  N Engl J Med       Date:  1979-01-04       Impact factor: 91.245

  7 in total
  23 in total

1.  In vitro efficacy of the combination of ciprofloxacin and cefotaxime against Vibrio vulnificus.

Authors:  Dong-Min Kim; Yong Lym; Sook Jin Jang; Hulin Han; Young Gi Kim; Choon-Hae Chung; Soon Pyo Hong
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 2.  The management of near drowning.

Authors:  J Pearn
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-23

3.  Inland presentation of Vibrio vulnificus primary septicemia and necrotizing fasciitis.

Authors:  R D Jenkins; J M Johnston
Journal:  West J Med       Date:  1986-01

Review 4.  A case of Vibrio vulnificus infection.

Authors:  T Ohta; R Kato; K Boku; M Kondo; H Kazui; K Naiki; H Tsuchioka; Y Inoue; H Noguchi; Y Takumi
Journal:  Jpn J Surg       Date:  1988-09

5.  Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection.

Authors:  Y C Chuang; W C Ko; S T Wang; J W Liu; C F Kuo; J J Wu; K Y Huang
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Vibrio vulnificus biogroup 2: new biogroup pathogenic for eels.

Authors:  D L Tison; M Nishibuchi; J D Greenwood; R J Seidler
Journal:  Appl Environ Microbiol       Date:  1982-09       Impact factor: 4.792

7.  New selective plating medium for isolation of Vibrio vulnificus biogroup 1.

Authors:  P R Brayton; P A West; E Russek; R R Colwell
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

8.  Pulmonary oedema, pneumonia and mortality in submersion victims; a retrospective study in 125 patients.

Authors:  M van Berkel; J J Bierens; R L Lie; T P de Rooy; L J Kool; E A van de Velde; A E Meinders
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

9.  Distribution and ecology of Vibrio vulnificus and other lactose-fermenting marine vibrios in coastal waters of the southeastern United States.

Authors:  J D Oliver; R A Warner; D R Cleland
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

10.  Comparative studies and laboratory diagnosis of Vibrio vulnificus, an invasive Vibrio sp.

Authors:  E P Desmond; J M Janda; F I Adams; E J Bottone
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.